GLP-1 Microdosing & Metabolic Optimization

“Microdosing” generally refers to using a lower dose of a GLP-1 medication than doses commonly used for weight management. There is not currently an FDA-approved GLP-1 dosing protocol specifically defined as “microdosing,” and this approach may involve off-label prescribing based on the provider’s clinical judgment and the individual patient.

Our goal is not simply to prescribe the lowest possible dose. It is to determine whether GLP-1 therapy is appropriate for you and, if so, use an individualized treatment plan while monitoring your response.

Metabolic optimization looks at the bigger picture. Depending on your individual needs, your plan may include:

• Medical evaluation and ongoing monitoring
• Review of relevant laboratory markers
• Body-composition monitoring
• Sleep and lifestyle factors
• Medication when medically appropriate

When medically appropriate, GLP-1 medications have been clinically shown to:

• Reduce appetite and hunger
• Improve blood sugar control
• Improve certain markers of metabolic health

Our individualized approach focuses on finding the appropriate treatment and dose for each patient based on medical history, goals, response, and tolerance.